Low dose cytarabine monotherapy for myelodysplastic syndromes
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
The main objective of this systematic review is to evaluate the efficacy and safety of low dose cytarabine for patients with MDS.